Reconnecting

The current page stays visible while onset.to reconnects in the background.

Clinicians Predict 220 to 20,000 Patients in the First Year After a U.S. Psychedelic Approval

Open original

Clinicians predicted that between 220 and 20,000 patients could receive psychedelic treatment in the first year after an initial U.S. FDA approval. At the Psychedelic Healthcare Forum, panelists estimated that a typical eligible patient might wait two to 36 months to book care, citing rescheduling, reimbursement and healthcare shortages. All expected the two-facilitator model common in trials to give way in practice. They stressed screening, safety protocols and education, while noting uncertainty about whether everyone needs therapy alongside medication. Access for poorer and unhoused patients could be constrained by unstable living conditions and community health center billing rules. Panelists also called for payment codes, provider collaboration and long-term outcomes data.